Latest Quarterly Activity Reports News

FINEOS Corporation Holdings PLC reports solid Q3 2025 results, highlighting revenue growth, operational efficiencies, and a key North American client migration to its SaaS platform, underpinning positive free cash flow expectations for FY25.

Rent.com.au reports a surge in recurring revenues driven by strong RentBond® loan growth, doubling monthly revenue run rates and advancing towards profitability.

G50 Corp’s latest quarterly report reveals a significant new precious metals discovery at its Golconda Project alongside promising antimony results at White Caps, supported by a $10 million capital raise to advance exploration.

Queste Communications reports steady investment holdings and a robust cash reserve of over $4 million for the quarter ending September 2025, underpinned by its controlling stake in Orion Equities.

Greatland Resources reported robust production in the September 2025 quarter, delivering nearly 81,000 ounces of gold and over 3,300 tonnes of copper, while boosting its cash reserves by $175 million.

Orthocell has reported a record $3 million revenue for the September quarter, driven by strong sales of its nerve repair product Remplir™ in Australia and Singapore, with early US sales and Canadian market entry poised to accelerate growth.

Future Metals NL has responded to an ASX price query following a sharp rise in its share price and trading volume, confirming no undisclosed information but highlighting progress on appointing a new CEO.

Connected Minerals has updated its quarterly reports for 2025 to provide detailed disclosures on the use of funds and exploration activities, addressing ASX compliance and shedding light on project developments in Namibia and Western Australia.

ActivePort Group has confirmed the mutual termination of its loan facility with Radian Arc and the lapse of a key licensing Term Sheet, clarifying its compliance with ASX disclosure rules.

Andromeda Metals has addressed recent share price gains and trading volume spikes, attributing the activity to ongoing funding efforts and strategic project studies rather than undisclosed information.

Nutritional Growth Solutions revises its Q2 FY25 financials, confirming stable revenue and detailing expanded distribution into CVS and Walmart. The company is actively raising capital to support growth and improve liquidity.

HeraMED Limited has resumed trading on the ASX following the release of its quarterly reports and a significant capital raising announcement, marking a pivotal moment for the medical device company.